Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients

This study aims at establishing relationships between genetic and non-genetic factors of variation of the pharmacokinetics of irinotecan and its metabolites; and also at establishing relationships between the pharmacokinetic or metabolic parameters and the efficacy and toxicity of irinotecan. We inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouits, E, Charasson, V, Pétain, A, Boisdron-Celle, M, Delord, J-P, Fonck, M, Laurand, A, Poirier, A-L, Morel, A, Chatelut, E, Robert, J, Gamelin, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570505/
https://www.ncbi.nlm.nih.gov/pubmed/18797458
http://dx.doi.org/10.1038/sj.bjc.6604673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570505/
https://www.ncbi.nlm.nih.gov/pubmed/18797458
http://dx.doi.org/10.1038/sj.bjc.6604673

Ejemplares similares